Description
Generic Version of Bosutinib Available in India?
Bosutinib is the generic name of the medication and is its international nonproprietary name. Bosutinib is marketed under the brand name Bonitar among others. It is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia.
Bosutinib received US FDA and EU European Medicines Agency approval in September 2012, and March 2013, respectively for the treatment of adults with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
Will this product be accessible across all regions of India?
The product – Bonitar (Bosutinib) Tablets will be available across India on request. Bosutinib is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
List of available brand-name drugs in India for Bosutinib
Branded Generic Drugs for Bosutinib: Bonitar
NEWS / Updates
- Robert J. Thomson; Majid Moshirfar; Yasmyne Ronquillo; Tyrosine Kinase Inhibitors, [Revised on 21st Jan 2021]; [Accessed on 22st April 2023]; https://www.ncbi.nlm.nih.gov/books/NBK563322/
- Novartis Pharmaceuticals UK Ltd, Electronic Medicines Compendium (EMC), [Revised on May 2022], [Accessed on 21st April 2023], https://www.medicines.org.uk/emc/product/5852
- Novartis, US Food & Drug Administration, [Revised on Sep 2021], [Accessed on 21st April 2023], https://www.novartis.us/sites/www.novartis.us/files/tasigna.pdf?
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
01 | June 2025 | 07:25 AM (IST)





